These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24577465)

  • 1. Brain-penetrating angiotensin-converting enzyme inhibitors and cognitive change in patients with dementia due to Alzheimer's disease.
    de Oliveira FF; Bertolucci PH; Chen ES; Smith MC
    J Alzheimers Dis; 2014; 42 Suppl 3():S321-4. PubMed ID: 24577465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics of Angiotensin-Converting Enzyme Inhibitors in Patients with Alzheimer's Disease Dementia.
    de Oliveira FF; Chen ES; Smith MC; Bertolucci PHF
    Curr Alzheimer Res; 2018 Feb; 15(4):386-398. PubMed ID: 29034839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetic effects of angiotensin-converting enzyme inhibitors over age-related urea and creatinine variations in patients with dementia due to Alzheimer disease.
    Ferreira de Oliveira F; Berretta JM; Suchi Chen E; Cardoso Smith M; Ferreira Bertolucci PH
    Colomb Med (Cali); 2016 Jun; 47(2):76-80. PubMed ID: 27546928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetic analyses of variations of measures of cardiovascular risk in Alzheimer's dementia.
    de Oliveira FF; Berretta JM; de Almeida Junior GV; de Almeida SS; Chen ES; Smith MC; Bertolucci PHF
    Indian J Med Res; 2019 Sep; 150(3):261-271. PubMed ID: 31719297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics of angiotensin modulators according to
    Oliveira FF; Almeida SS; Chen ES; Smith MC; Bertolucci PHF
    Acta Neuropsychiatr; 2023 Dec; 35(6):346-361. PubMed ID: 37605989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease.
    Dong YF; Kataoka K; Tokutomi Y; Nako H; Nakamura T; Toyama K; Sueta D; Koibuchi N; Yamamoto E; Ogawa H; Kim-Mitsuyama S
    FASEB J; 2011 Sep; 25(9):2911-20. PubMed ID: 21593435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of centrally acting angiotensin converting enzyme inhibitors on functional decline in patients with Alzheimer's disease.
    O'Caoimh R; Healy L; Gao Y; Svendrovski A; Kerins DM; Eustace J; Kehoe PG; Guyatt G; Molloy DW
    J Alzheimers Dis; 2014; 40(3):595-603. PubMed ID: 24496072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can angiotensin-converting enzyme inhibitors impact cognitive decline in early stages of Alzheimer's disease? An overview of research evidence in the elderly patient population.
    Rygiel K
    J Postgrad Med; 2016; 62(4):242-248. PubMed ID: 27763482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin converting enzyme serum activities: Relationship with Alzheimer's disease.
    Zhuang S; Wang X; Wang HF; Li J; Wang HY; Zhang HZ; Xing CM
    Brain Res; 2016 Nov; 1650():196-202. PubMed ID: 27608957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors.
    Fournier A; Oprisiu-Fournier R; Serot JM; Godefroy O; Achard JM; Faure S; Mazouz H; Temmar M; Albu A; Bordet R; Hanon O; Gueyffier F; Wang J; Black S; Sato N
    Expert Rev Neurother; 2009 Sep; 9(9):1413-31. PubMed ID: 19769454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-converting enzyme inhibitors and Alzheimer's disease progression in older adults: results from the Réseau sur la Maladie d'Alzheimer Français cohort.
    Soto ME; van Kan GA; Nourhashemi F; Gillette-Guyonnet S; Cesari M; Cantet C; Rolland Y; Vellas B
    J Am Geriatr Soc; 2013 Sep; 61(9):1482-8. PubMed ID: 24000874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a centrally active angiotensin-converting enzyme inhibitor, perindopril, on cognitive performance in a mouse model of Alzheimer's disease.
    Yamada K; Uchida S; Takahashi S; Takayama M; Nagata Y; Suzuki N; Shirakura S; Kanda T
    Brain Res; 2010 Sep; 1352():176-86. PubMed ID: 20627092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early onset Alzheimer's disease is associated with a distinct neuropsychological profile.
    Smits LL; Pijnenburg YA; Koedam EL; van der Vlies AE; Reuling IE; Koene T; Teunissen CE; Scheltens P; van der Flier WM
    J Alzheimers Dis; 2012; 30(1):101-8. PubMed ID: 22366769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomics in Alzheimer's disease.
    Cacabelos R
    Methods Mol Biol; 2008; 448():213-357. PubMed ID: 18370236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multi-center study of ACE and the risk of late-onset Alzheimer's disease.
    Belbin O; Brown K; Shi H; Medway C; Abraham R; Passmore P; Mann D; Smith AD; Holmes C; McGuinness B; Craig D; Warden D; Heun R; Kölsch H; Love S; Kalsheker N; Williams J; Owen MJ; Carrasquillo M; Younkin S; Morgan K; Kehoe PG
    J Alzheimers Dis; 2011; 24(3):587-97. PubMed ID: 21297258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.
    Cacabelos R
    Methods Find Exp Clin Pharmacol; 2007 Jul; 29 Suppl A():1-91. PubMed ID: 17957277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme insertion/deletion polymorphism and the longitudinal progression of Alzheimer's disease.
    Chou PS; Wu MN; Chou MC; Chien I; Yang YH
    Geriatr Gerontol Int; 2017 Oct; 17(10):1544-1550. PubMed ID: 27862810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Entorhinal cortex thickness predicts cognitive decline in Alzheimer's disease.
    Velayudhan L; Proitsi P; Westman E; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Spenger C; Hodges A; Powell J; Lovestone S; Simmons A;
    J Alzheimers Dis; 2013; 33(3):755-66. PubMed ID: 23047370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem cell factor plasma levels are decreased in Alzheimer's disease patients with fast cognitive decline after one-year follow-up period: the Pythia-study.
    Laske C; Sopova K; Hoffmann N; Stransky E; Hagen K; Fallgatter AJ; Stellos K; Leyhe T
    J Alzheimers Dis; 2011; 26(1):39-45. PubMed ID: 21593573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of cerebrovascular metabolism genotypes with neuropsychiatric symptoms and age at onset of Alzheimer's disease dementia.
    Oliveira FF; Chen ES; Smith MC; Bertolucci PH
    Braz J Psychiatry; 2017; 39(2):95-103. PubMed ID: 28099631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.